Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents

Twenty six new pyrazoline substituted benzenesulfonylurea derivatives (2a–z) were synthesized and characterized. Out of these fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were evaluated for their antiproliferative activity towards 60 human cancer cell lines. Twenty six new pyrazoline substituted benz...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 24; no. 7; pp. 1685 - 1691
Main Authors Rathore, Pooja, Yaseen, Shafiya, Ovais, Syed, Bashir, Rafia, Yaseen, Raed, Hameed, Alhamzah D., Samim, Mohammed, Gupta, Rakesh, Hussain, Firasat, Javed, Kalim
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.04.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Twenty six new pyrazoline substituted benzenesulfonylurea derivatives (2a–z) were synthesized and characterized. Out of these fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were evaluated for their antiproliferative activity towards 60 human cancer cell lines. Twenty six new pyrazoline substituted benzenesulfonylureas (2a–z) were synthesized and tested for in vitro anticancer activity. Fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were screened for their antiproliferative activity towards 60 human cancer cell lines by the National Cancer Institute (USA). Among them four compounds (2i, 2n, 2v and 2x) exhibited significant growth inhibition and further screened at 10-fold dilutions of five different concentrations (0.01, 0.1, 1, 10 and 100μM). The compounds 2i, 2n, 2v and 2x showed effective growth inhibition (GI50 MID) values of 2.62, 3.93, 3.33, 3.74μM respectively beside cytostatic activity TGI (MG-MID) values of 8.42, 65.80, 24.00 and 36.06μM respectively. The compound 2i displayed remarkable antiproliferative activity in 8 different cell lines with GI50 less than 2μM. Compounds 2n, 2v and 2x also displayed good antiproliferative activity against 11, 18 and 14 different cell lines respectively with GI50 less than 3μM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2014.02.059